Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1
- PMID: 7515931
Dissociation rate of antibody-gp120 binding interactions is predictive of V3-mediated neutralization of HIV-1
Abstract
mAbs specific for the V3 loop of HIV-1 are capable of neutralizing laboratory strains of HIV-1 in vitro. In this report we use surface plasmon resonance and biosensor technology to demonstrate that the ability of V3-specific mAbs to neutralize HIV-1(MN) correlated with the dissociation rate constant of the homologous mAb-gp120 binding interaction. mAbs capable of binding diverse strains of gp120 with similar association rate constants exhibited marked differences in the dissociation rate. The dissociation rate, and not the association rate, was found to be predictive of the neutralization capacity of the mAb. Furthermore, synthetic peptides corresponding to the V3 loop of HIV-1(IIIB, MN) yielded quantitatively similar binding kinetic profiles abrogating the need for purified recombinant gp120 protein and potentially facilitating the screening of more diverse isolates. Biosensor immobilized V3 peptides were found to mimic their conformational structure in solution. This offers advantages to peptides studied by ELISA where some degree of denaturation and masking of epitopes can occur upon adsorption of peptides to plastic surfaces. The impact of amino acid substitutions within epitopes on subsequent mAb binding was dissected by observing alterations in dissociation rates. The technique provides rapid kinetic analyses of V3 Ab binding interactions with diverse V3 sequences, facilitating the efficient screening and selection of those most likely to possess the broadest and most potent HIV-1 neutralizing potentials.
Similar articles
-
Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.Biochem J. 2006 Nov 1;399(3):483-91. doi: 10.1042/BJ20060588. Biochem J. 2006. PMID: 16827663 Free PMC article.
-
Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.Virology. 1997 Mar 17;229(2):360-9. doi: 10.1006/viro.1997.8443. Virology. 1997. PMID: 9126249
-
Permissive residues within the minimal epitopes of neutralizing monoclonal antibodies to the V3 loop of HIV-1.Eur J Immunol. 1996 Jul;26(7):1634-40. doi: 10.1002/eji.1830260734. Eur J Immunol. 1996. PMID: 8766572
-
Induced fit in HIV-neutralizing antibody complexes: evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.Biochemistry. 2005 May 17;44(19):7250-8. doi: 10.1021/bi047387t. Biochemistry. 2005. PMID: 15882063
-
Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.AIDS. 1994 Feb;8(2):169-81. AIDS. 1994. PMID: 7519019
Cited by
-
Modeling neutralization kinetics of HIV by broadly neutralizing monoclonal antibodies in genital secretions coating the cervicovaginal mucosa.PLoS One. 2014 Jun 26;9(6):e100598. doi: 10.1371/journal.pone.0100598. eCollection 2014. PLoS One. 2014. PMID: 24967706 Free PMC article.
-
The antigenicity of tobacco mosaic virus.Philos Trans R Soc Lond B Biol Sci. 1999 Mar 29;354(1383):559-68. doi: 10.1098/rstb.1999.0407. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10212935 Free PMC article. Review.
-
Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.J Virol. 1998 Sep;72(9):6988-96. doi: 10.1128/JVI.72.9.6988-6996.1998. J Virol. 1998. PMID: 9696790 Free PMC article.
-
Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.J Virol. 1997 Oct;71(10):7198-206. doi: 10.1128/JVI.71.10.7198-7206.1997. J Virol. 1997. PMID: 9311792 Free PMC article.
-
Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strains.J Virol. 2005 Oct;79(19):12311-20. doi: 10.1128/JVI.79.19.12311-12320.2005. J Virol. 2005. PMID: 16160158 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources